Oren Pasvolsky

32PUBLICATIONS
107CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunologyImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 24, 2026
Prognostic impact of monosomy 13 and deletion of 13q in multiple myeloma patients undergoing upfront autologous transplantation.

|Jul 06, 2026
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma.

|Jun 05, 2026
D-VRD induction and autologous transplant in patients ≥70 years.

|Apr 13, 2026
Association of genetic ancestry with outcomes and toxicity of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma.

Christen M Dillard, Hans Lee, Nilesh Kalariya

|Mar 28, 2026
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.

Andrew J Portuguese, James A Davis, Shahzad Raza

|Mar 21, 2026
The Safety and Efficacy of Commercial BCMA-Directed CAR T-Cell Therapy in Systemic AL Amyloidosis With Concurrent Myeloma.

Matthew J Rees, Raffaella Cassano Cassano, Melinda Tan

Pageof 6

Frequent Collaborators

14 joint publications

Hans C Lee

10 joint publications

Krina Patel

8 joint publications

Surbhi Sidana

8 joint publications

Rahul Banerjee